What is ADXN's health score?

Addex Therapeutics Ltd. (ADXN) has a TradeApes health score of 34 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ADXN's estimated fair value?

Based on our 5-year discounted cash flow model, Addex Therapeutics Ltd.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ADXN undervalued or overvalued?

Our model currently rates ADXN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ADXN... Refresh in a moment for the full analysis.

Addex Therapeutics Ltd. (ADXN)

Healthcare Inconclusive inconclusive weak

$6.65

Updated: 2026-05-30

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

40 Weak

Relative Value

20 Stressed

Capital Allocation

30 Weak

Risk

80 Strong

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.